BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30695676)

  • 1. MicroRNAs in peritoneal fibrosis: a systematic review.
    Yanai K; Ishii H; Aomatsu A; Ishibashi K; Morishita Y
    Discov Med; 2018 Dec; 26(145):271-280. PubMed ID: 30695676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in peritoneal dialysis effluent are promising biomarkers for peritoneal fibrosis in peritoneal dialysis patients.
    Ge Y; Xiao L; Chen X; Peng Y; Sun L; Liu F
    Med Hypotheses; 2012 Jan; 78(1):155-6. PubMed ID: 22056978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis.
    Lin F; Wu X; Zhang H; You X; Zhang Z; Shao R; Huang C
    BMC Nephrol; 2015 Apr; 16():48. PubMed ID: 25884636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression profiling and ontology analysis of noncoding RNAs in peritoneal fibrosis induced by peritoneal dialysis fluid.
    Liu Y; Guo R; Hao G; Xiao J; Bao Y; Zhou J; Chen Q; Wei X
    Gene; 2015 Jun; 564(2):210-9. PubMed ID: 25827714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNAs in peritoneal fibrosis: Background, Mechanism, and Therapeutic Approach.
    Guo Y; Wang L; Gou R; Tang L; Liu P
    Biomed Pharmacother; 2020 Sep; 129():110385. PubMed ID: 32768932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression profiling in peritoneal fibrosis.
    Morishita Y; Yoshizawa H; Watanabe M; Imai R; Imai T; Hirahara I; Akimoto T; Ookawara S; Muto S; Nagata D
    Transl Res; 2016 Mar; 169():47-66. PubMed ID: 26616819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
    Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
    Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal fibrosis and epigenetic modulation.
    Wang Y; Shi Y; Tao M; Zhuang S; Liu N
    Perit Dial Int; 2021 Mar; 41(2):168-178. PubMed ID: 32662737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA regulation of peritoneal cavity homeostasis in peritoneal dialysis.
    Lopez-Anton M; Bowen T; Jenkins RH
    Biomed Res Int; 2015; 2015():929806. PubMed ID: 26495316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment.
    Habib SM; Betjes MG; Fieren MW; Boeschoten EW; Abrahams AC; Boer WH; Struijk DG; Ruger W; Krikke C; Westerhuis R; de Sévaux RG; van der Sande FM; Gaasbeek A; Korte MR;
    Neth J Med; 2011; 69(11):500-7. PubMed ID: 22173363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulating peritoneal sclerosis--a complication of peritoneal dialysis.
    Chembo C; Macdonald A; Hay N; Matheson P; Pidgeon G; Leikis M
    N Z Med J; 2011 Sep; 124(1342):89-93. PubMed ID: 21963929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Encapsulating peritoneal sclerosis].
    Ryckelynck JP; Béchade C; Bouvier N; Ficheux M; Hurault de Ligny B; Lobbedez T
    Nephrol Ther; 2017 Jun; 13(4):211-219. PubMed ID: 28576435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Past and present perspectives on encapsulating peritoneal sclerosis.
    Kawanishi H; Shintaku S; Banshodani M; Hashimoto S
    Contrib Nephrol; 2015; 185():87-97. PubMed ID: 26023018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis.
    Costalonga EC; de Freitas LJ; Aragone DDSP; Silva FMO; Noronha IL
    PLoS One; 2017; 12(9):e0184302. PubMed ID: 28873458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: update from Japan.
    Nakayama M; Terawaki H
    Int J Urol; 2014 Aug; 21(8):755-61. PubMed ID: 24673567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene delivery in peritoneal dialysis related peritoneal fibrosis research.
    Li XJ; Sun L; Xiao L; Liu FY
    Chin Med J (Engl); 2012 Jun; 125(12):2219-24. PubMed ID: 22884156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.
    Zhou Q; Bajo MA; Del Peso G; Yu X; Selgas R
    Kidney Int; 2016 Sep; 90(3):515-24. PubMed ID: 27282936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MicroRNA-199a/214 Cluster Targets E-Cadherin and Claudin-2 and Promotes High Glucose-Induced Peritoneal Fibrosis.
    Che M; Shi T; Feng S; Li H; Zhang X; Feng N; Lou W; Dou J; Tang G; Huang C; Xu G; Qian Q; Sun S; He L; Wang H
    J Am Soc Nephrol; 2017 Aug; 28(8):2459-2471. PubMed ID: 28428333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulating peritoneal sclerosis.
    Jakimowicz T; Wojtaszek E; Augustine T; Grzejszczak A; Matuszkiewicz-Rowińska J
    Pol Arch Med Wewn; 2013; 123(3):125-6. PubMed ID: 23535858
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-Term Success with Adhesiolysis in Post-Transplant Encapsulating Peritoneal Sclerosis: A Retrospective Case Series of 4 Patients and Review of the Literature.
    Oguz EG; Okyay GU; Merhametsiz O; Ersoz S; Canbakan B; Ayli D
    Intern Med; 2016; 55(3):269-72. PubMed ID: 26831022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.